Perioperative Indications for Gabapentinoids in Pediatrics: A Narrative Review
- PMID: 36434428
- PMCID: PMC9836387
- DOI: 10.1007/s40272-022-00545-8
Perioperative Indications for Gabapentinoids in Pediatrics: A Narrative Review
Abstract
In recent years, there has been increased interest in using gabapentinoids (gabapentin and pregabalin) as part of multimodal medication plans or enhanced recovery after surgery protocols to mitigate several perioperative clinical challenges. Outcomes explored in the context of using gabapentinoids perioperatively in children are variable and include acute complications of pain, anxiety, nausea and vomiting, and emergence agitation, as well as the long-term postoperative outcome of chronic postsurgical pain. This narrative review describes the current literature regarding perioperative use of gabapentinoids in pediatric patients and aims to describe the role of gabapentinoids in the perioperative setting for each specific indication.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
References
-
- Lyrica (pregabalin) [package insert]. New York City, NY: Pfizer, Inc. https://labeling.pfizer.com/showlabeling.aspx?id=9678. Published June 2020. Accessed October 25, 2022.
-
- Neurontin (gabapentin) [package insert]. New York City, NY: Pfizer, Inc. https://labeling.pfizer.com/ShowLabeling.aspx?id=630. Published October 2021. Accessed October 25, 2022.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
